UNSPSC 41141512: Edta standards

In this classification, this entry connotes a standardized formulation of Edta used to conduct Anion tests.

UNSPSC 41141512 Edta standards (Commodity) covers certified reference materials and analytical reagent kits that state and local forensic laboratories, public health agencies, and law enforcement use for drug analysis, toxicology validation, and substance identification. Recent solicitations show state and local governments procuring direct ELISA testing kits, drug reference standards with documented purity and certificates of analysis meeting ISO/IEC 17025 accreditation, DNA screening kits, and immunoanalysis reagents for evidentiary sample analysis and analytical method validation. The issuing bodies are predominantly state law enforcement and public health agencies—the Texas Department of Public Safety, Texas Department of Criminal Justice, Texas Health and Human Services Commission, Illinois Department of Financial and Professional Regulation, and Pinellas County, Florida in partnership with the Florida Department of Law Enforcement—along with county forensic laboratories serving multiple jurisdictions through state-directed procurement mechanisms.

Recent activity concentrates in Texas and Florida. The Texas Department of Public Safety issued an IFB due July 23, 2026 for direct ELISA testing kits (12 line items, cannabinoids through benzodiazepines) under sole-source authorization, evaluating vendors on best value with performance-rating disqualifications for vendors below C grade or with active corrective action plans. Pinellas County, Florida, through ITQ 26-0305-ITQ (due April 23, 2026), procured 131 line items of drug standards meeting ISO/IEC 17025:2017 and ISO 17034:2016 standards with purity exceeding 97%, funded through the Paul Coverdell Forensic Sciences Improvement Act Program with approximately $49,034.00 designated for supplies and equipment; SBEs submitting within five business days received priority consideration, with others receiving five percent price preference. The Texas Health and Human Services Commission issued IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits (due January 29, 2026) with historical fiscal-year value between $25,050.00 and $30,000.00, evaluating on best value through January 2026 with contract extension option through August 2026. Cooperative purchasing and sole-source procurement models are common, with HUB subcontracting plans encouraged or required depending on the jurisdiction.